HRTX FY 2014 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$55M

Operating Income

-$75M

Net Income

-$76M

EPS (Diluted)

$-2.87

Cash Flow

Operating Cash Flow

-$60M

Free Cash Flow

-$62M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$77M

Total Liabilities

$14M

Stockholders' Equity

$63M

Cash & Equivalents

$73M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$55M	-$31M	-77.4%
Operating Income	-$75M	-$54M	-36.9%
Net Income	-$76M	-$55M	-38.1%